the current role for antiangiogenic therapy for nsclc
Published 7 years ago • 310 plays • Length 9:12Download video MP4
Download video MP3
Similar videos
-
6:01
future directions for antiangiogenic therapy in lung cancer
-
6:32
antiangiogenic therapy for metastatic colorectal cancer
-
6:11
how does antiangiogenic therapy work?
-
4:15
current concepts in anti-angiogenic therapy for non-small cell lung cancer
-
5:43
antiangiogenic therapy in advanced nsclc
-
5:29
mechanisms of anti-angiogenic therapy in lung cancer
-
3:00
nsclc: mechanisms of resistance to antiangiogenic therapy
-
3:05
rationale behind antiangiogenic therapy in nsclc
-
3:02
using antiangiogenic therapy in stage 4 nsclc
-
5:29
resistance to antiangiogenic therapy in lung cancer
-
2:37
considerations for antiangiogenic therapy in nsclc
-
1:59
antiangiogenic therapy in nsclc
-
2:05
mark socinski, md: antiangiogenic therapy in nsclc
-
4:21
current concepts in anti-angiogenic therapy for non-small cell lung cancer.mp4
-
22:35
expert perspectives: anti-angiogenesis and immune therapy for cancer
-
3:56
antiangiogenic antibodies vs tkis in nsclc
-
3:55
sequencing and combining therapies with antiangiogenic monoclonal antibodies
-
24:23
targeting angiogenesis in nsclc
-
4:36
efficacy and safety of checkpoint inhibitors in lung cancer